Trial Profile
Pharmacokinetics and Safety of Intravenous Cidofovir for Life-Threatening Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Cidofovir (Primary)
- Indications Viral infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Gilead Sciences
- 30 Oct 2015 New trial record